Korean J Dermatol.
2015 May;53(4):319-323.
Adalimumab-induced Lupus Erythematosus Profundus in a Rheumatoid Arthritis Patient
- Affiliations
-
- 1Department of Dermatology, School of Medicine, Keimyung University, Deagu, Korea. franzes@dsmc.or.kr
Abstract
- The clinical manifestations and immunohistologic findings of drug-induced lupus erythematosus (DILE) are similar to those of idiopathic lupus. However, DILE is different from idiopathic lupus because it is induced after continuous drug exposure and resolves after discontinuation of the causative drug. DILE can be divided into systemic lupus erythematosus, subacute cutaneous lupus erythematosus, and chronic cutaneous lupus erythematosus (CCLE). Lupus erythematosus profundus is a subtype of CCLE, and drug-induced CCLE is very rarely reported in the literature. Herein, we report a rare case of adalimumab-induced lupus erythematosus profundus developed in a rheumatoid arthritis patient. The patient is a 43-year-old Korean woman who had multiple tender nodules and plaques on her face, trunk, and both extremities after using adalimumab for rheumatoid arthritis. She was diagnosed with adalimumab-induced lupus erythematosus profundus, and her condition improved after discontinuation of adalimumab.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Lupus Erythematosus Profundus
- A Case of Rheumatoid Nodule in a Systemic Lupus Erythematosus Patient
- Lupus Profundus with Segmental Distribution on Leg, Following the Lines of Blaschko in a Child
- Sequential Development of Systemic Lupus Erythematosus in a Patient with Juvenile Rheumatoid Arthritis
- Unusual Cutaneous Manifestations of Connective Tissue Diseases III. Lupus Erythematosus Profundus Developed on the Discoid Cutaneous Lesions
